Atomoxetine
Atomoxetine is a generic medication used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It works by increasing norepinephrine levels in the brain to improve focus and impulse control. Available as oral capsules in strengths of 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg, manufactured by Camber Pharmaceuticals, Inc. under ANDA202682. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Atomoxetine is a generic medication used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It works by increasing norepinephrine levels in the brain to improve focus and impulse control. Available as oral capsules in strengths of 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg, manufactured by Camber Pharmaceuticals, Inc. under ANDA202682. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Atomoxetine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Atomoxetine — ANDA 021411 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021411"
}
]
|
| identifier | ANDA021411 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"health-care",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Atomoxetine |
